Results
|
41.
|
Dipeptidyl-peptidase-IV inhibition augments postprandial lipid mobilization and oxidation in type 2 diabetic patients. [electronic resource] by
- Boschmann, Michael
- Engeli, Stefan
- Dobberstein, Kerstin
- Budziarek, Petra
- Strauss, Anke
- Boehnke, Jana
- Sweep, Fred C G J
- Luft, Friedrich C
- He, Yanling
- Foley, James E
- Jordan, Jens
Producer: 20090407
In:
The Journal of clinical endocrinology and metabolism vol. 94
Availability: No items available.
|
|
42.
|
The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study. [electronic resource] by
- Vella, Adrian
- Bock, Gerlies
- Giesler, Paula D
- Burton, Duane B
- Serra, Denise B
- Saylan, Monica Ligueros
- Deacon, Carolyn F
- Foley, James E
- Rizza, Robert A
- Camilleri, Michael
Producer: 20090820
In:
Clinical endocrinology vol. 69
Availability: No items available.
|
|
43.
|
Dipeptidyl peptidase-4 inhibition by vildagliptin and the effect on insulin secretion and action in response to meal ingestion in type 2 diabetes. [electronic resource] by
- Dalla Man, Chiara
- Bock, Gerlies
- Giesler, Paula D
- Serra, Denise B
- Ligueros Saylan, Monica
- Foley, James E
- Camilleri, Michael
- Toffolo, Gianna
- Cobelli, Claudio
- Rizza, Robert A
- Vella, Adrian
Producer: 20130103
In:
Diabetes care vol. 32
Availability: No items available.
|
|
44.
|
Treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin improves fasting islet-cell function in subjects with type 2 diabetes. [electronic resource] by
- D'Alessio, David A
- Denney, Amanda M
- Hermiller, Linda M
- Prigeon, Ronald L
- Martin, Julie M
- Tharp, William G
- Saylan, Monica Liqueros
- He, Yanling
- Dunning, Beth E
- Foley, James E
- Pratley, Richard E
Producer: 20090212
In:
The Journal of clinical endocrinology and metabolism vol. 94
Availability: No items available.
|
|
45.
|
The dipeptidyl peptidase-4 inhibitor vildagliptin improves beta-cell function and insulin sensitivity in subjects with impaired fasting glucose. [electronic resource] by
- Utzschneider, Kristina M
- Tong, Jenny
- Montgomery, Brenda
- Udayasankar, Jayalakshmi
- Gerchman, Fernando
- Marcovina, Santica M
- Watson, Catherine E
- Ligueros-Saylan, Monica A
- Foley, James E
- Holst, Jens J
- Deacon, Carolyn F
- Kahn, Steven E
Producer: 20080116
In:
Diabetes care vol. 31
Availability: No items available.
|
|
46.
|
The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients. [electronic resource] by
- Balas, Bogdan
- Baig, Muhammad R
- Watson, Catherine
- Dunning, Beth E
- Ligueros-Saylan, Monica
- Wang, Yibin
- He, Yan-Ling
- Darland, Celia
- Holst, Jens J
- Deacon, Carolyn F
- Cusi, Kenneth
- Mari, Andrea
- Foley, James E
- DeFronzo, Ralph A
Producer: 20070917
In:
The Journal of clinical endocrinology and metabolism vol. 92
Availability: No items available.
|
|
47.
|
Measurements of islet function and glucose metabolism with the dipeptidyl peptidase 4 inhibitor vildagliptin in patients with type 2 diabetes. [electronic resource] by
- Azuma, Koichiro
- Rádiková, Zofia
- Mancino, Juliet
- Toledo, Frederico G S
- Thomas, Ernestine
- Kangani, Cyrous
- Dalla Man, Chiara
- Cobelli, Claudio
- Holst, Jens J
- Deacon, Carolyn F
- He, Yanling
- Ligueros-Saylan, Monica
- Serra, Denise
- Foley, James E
- Kelley, David E
Producer: 20080410
In:
The Journal of clinical endocrinology and metabolism vol. 93
Availability: No items available.
|